Affordable Development: Biotechnology, Economics and the Implications for the Third World

Booknews

Analyzes the economic and financial experience of such biological advances as recombinant DNA, monoclonal antibodies, and novel processing techniques in the industrialized world, and draws implications for their use in developing countries. Though recognizing the concurrent need for an adequate scientific and technical workforce, focuses mainly on the economics and financing of biotechnology, particularly during the 10-12 years it takes to develop a commercial product. Concludes that diagnostics based on monoclonal antibodies are the best suited to the resources usually available, and can provide a foundation from which other aspects can grow. Paper edition (unseen), $22.50. Distributed in the US by Humanities Press. Annotation c. Book News, Inc., Portland, OR (booknews.com)